StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for ESTA yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-15 | $68.62 | $65.76 | -4.17% | 0.5M |
| 05-18 | $65.62 | $65.63 | +0.02% | 0.4M |
| 05-19 | $65.08 | $65.55 | +0.72% | 0.3M |
| 05-20 | $66.88 | $70.04 | +4.72% | 0.4M |
| 05-21 | $69.93 | $71.38 | +2.07% | 0.2M |
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Aggregated from Polygon's per-article sentiment classifications. Educational — sentiment is descriptive, not predictive.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $59.88M | $211.08M | $146.46M | $92.68M |
Operating Income | $-6.51M | $-39.01M | $-35.08M | $-31.05M |
Net Income | $-13.38M | $-51.06M | $-48.45M | $-16.59M |
EPS (Diluted) | $-0.45 | $-1.72 | $-1.64 | $-1.29 |
Total Assets | $351.04M | $357.17M | $338.89M | $329.67M |
Total Liabilities | $336.25M | $333.62M | $322.53M | $306.90M |
Cash & Equivalents | $68.10M | $75.57M | $70.62M | $54.64M |
Free Cash Flow OCF − CapEx | $-6.16M | $-56.94M | $-54.95M | $-41.85M |
Shares Outstanding | 29.39M | 29.30M | 29.06M | 28.97M |
ESTA is in the extended universe. We surface dollar-volume + price-change percentiles for every US-listed name, but the full 6-factor DNA breakdown (momentum, news, sentiment, flow, relative strength) is only computed on the curated 1137-name primary list.
DNA analysis is not available for this ticker.
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.